• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

The Changing Landscape of Digital Trials


Richard Young, Vice President of Strategy, Vault CDMS and Tim Davis, Vice President of Strategy, MyVeeva for Patients, discuss the future of digital trials and their impact in the industry.

  • It is important to not get caught up on the terminology involved in the new landscape for clinical trials; digital is the how while decentralized is where a trial is done.
  • The patient experience within digital trials can be improved by streamlining information and access into a single application.
  • Veeva takes an end-to-end approach with clinical trials so patients can participate in them, while taking into consideration their routines and lifestyles.
Recent Videos
Jason Tate, FSP Talent Strategy Lead, PPD, part of Thermo Fisher Scientific
Corevitas Clinical Trials